EU slaps $475m fine on Illumina for preemptive acquisition of grail
The European Union (EU) has imposed a hefty fine of $475 million on Illumina, a leading U.S. biotech company, for...
The European Union (EU) has imposed a hefty fine of $475 million on Illumina, a leading U.S. biotech company, for...